ArticleLeukemia research2012

Directed therapy for patients with myelodysplastic syndromes (MDS) by suppression of cyclin D1 with ON 01910.Na.

Matthew J Olnes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.